Search research articles
Contact Us
Filters
Showing results (251-260 of 259) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 259 results.
Journal of Neurology
|
June 14, 2016
Re-review of MRI with post-processing in nonlesional patients in whom epilepsy surgery has failed
Z Irene Wang, P Suwanpakdee, S E Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2002
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer
F A Holmes, S E Jones, J O'Shaughnessy, et al.
AJNR. American Journal of Neuroradiology
|
September 10, 2016
Automated MRI Volumetric Analysis in Patients with Rasmussen Syndrome
Z I Wang, B Krishnan, D W Shattuck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer
V Valero, S E Jones, D D Von Hoff, et al.
Scientific Reports
|
August 30, 2018
Estimating sleep parameters using an accelerometer without sleep diary
Vincent Theodoor van Hees, S Sabia, S E Jones, et al.
Clinical Breast Cancer
|
April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
S M Swain, F S Whaley, M C Gerber, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 259) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 259 results.
Journal of Neurology
|
June 14, 2016
Re-review of MRI with post-processing in nonlesional patients in whom epilepsy surgery has failed
Z Irene Wang, P Suwanpakdee, S E Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2002
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer
F A Holmes, S E Jones, J O'Shaughnessy, et al.
AJNR. American Journal of Neuroradiology
|
September 10, 2016
Automated MRI Volumetric Analysis in Patients with Rasmussen Syndrome
Z I Wang, B Krishnan, D W Shattuck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer
V Valero, S E Jones, D D Von Hoff, et al.
Scientific Reports
|
August 30, 2018
Estimating sleep parameters using an accelerometer without sleep diary
Vincent Theodoor van Hees, S Sabia, S E Jones, et al.
Clinical Breast Cancer
|
April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
S M Swain, F S Whaley, M C Gerber, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Page
of 26